188 related articles for article (PubMed ID: 28978999)
1. Low-dose YC-1 combined with glucose and insulin selectively induces apoptosis in hypoxic gastric carcinoma cells by inhibiting anaerobic glycolysis.
Wakiyama K; Kitajima Y; Tanaka T; Kaneki M; Yanagihara K; Aishima S; Nakamura J; Noshiro H
Sci Rep; 2017 Oct; 7(1):12653. PubMed ID: 28978999
[TBL] [Abstract][Full Text] [Related]
2. The Apoptotic Effect of HIF-1α Inhibition Combined with Glucose plus Insulin Treatment on Gastric Cancer under Hypoxic Conditions.
Tanaka T; Kitajima Y; Miyake S; Yanagihara K; Hara H; Nishijima-Matsunobu A; Baba K; Shida M; Wakiyama K; Nakamura J; Noshiro H
PLoS One; 2015; 10(9):e0137257. PubMed ID: 26339797
[TBL] [Abstract][Full Text] [Related]
3. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells.
Zhao Q; Du J; Gu H; Teng X; Zhang Q; Qin H; Liu N
Pancreas; 2007 Mar; 34(2):242-7. PubMed ID: 17312464
[TBL] [Abstract][Full Text] [Related]
4. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
[TBL] [Abstract][Full Text] [Related]
5. YC-1 sensitizes the antitumor effects of boron neutron capture therapy in hypoxic tumor cells.
Harada T; Hirose K; Wada Y; Sato M; Ichise K; Aoki M; Kato T; Takeda K; Takai Y
J Radiat Res; 2020 Jul; 61(4):524-534. PubMed ID: 32367141
[TBL] [Abstract][Full Text] [Related]
6. Basic fibroblast growth factor regulates glucose metabolism through glucose transporter 1 induced by hypoxia-inducible factor-1α in adipocytes.
Kihira Y; Yamano N; Izawa-Ishizawa Y; Ishizawa K; Ikeda Y; Tsuchiya K; Tamaki T; Tomita S
Int J Biochem Cell Biol; 2011 Nov; 43(11):1602-11. PubMed ID: 21810481
[TBL] [Abstract][Full Text] [Related]
7. Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.
Leung E; Cairns RA; Chaudary N; Vellanki RN; Kalliomaki T; Moriyama EH; Mujcic H; Wilson BC; Wouters BG; Hill R; Milosevic M
BMC Cancer; 2017 Jun; 17(1):418. PubMed ID: 28619042
[TBL] [Abstract][Full Text] [Related]
8. YC-1 induces S cell cycle arrest and apoptosis by activating checkpoint kinases.
Yeo EJ; Ryu JH; Chun YS; Cho YS; Jang IJ; Cho H; Kim J; Kim MS; Park JW
Cancer Res; 2006 Jun; 66(12):6345-52. PubMed ID: 16778212
[TBL] [Abstract][Full Text] [Related]
9. YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1.
Yeo EJ; Chun YS; Cho YS; Kim J; Lee JC; Kim MS; Park JW
J Natl Cancer Inst; 2003 Apr; 95(7):516-25. PubMed ID: 12671019
[TBL] [Abstract][Full Text] [Related]
10. Impaired mitophagy activates mtROS/HIF-1α interplay and increases cancer aggressiveness in gastric cancer cells under hypoxia.
Shida M; Kitajima Y; Nakamura J; Yanagihara K; Baba K; Wakiyama K; Noshiro H
Int J Oncol; 2016 Apr; 48(4):1379-90. PubMed ID: 26820502
[TBL] [Abstract][Full Text] [Related]
11. A HIF-1α inhibitor combined with palmitic acid and L-carnitine treatment can prevent the fat metabolic reprogramming under hypoxia and induce apoptosis in hepatocellular carcinoma cells.
Matsufuji S; Kitajima Y; Higure K; Kimura N; Maeda S; Yamada K; Ito K; Tanaka T; Kai K; Noshiro H
Cancer Metab; 2023 Dec; 11(1):25. PubMed ID: 38066600
[TBL] [Abstract][Full Text] [Related]
12. Wortmannin influences hypoxia-inducible factor-1 alpha expression and glycolysis in esophageal carcinoma cells.
Zeng L; Zhou HY; Tang NN; Zhang WF; He GJ; Hao B; Feng YD; Zhu H
World J Gastroenterol; 2016 May; 22(20):4868-80. PubMed ID: 27239113
[TBL] [Abstract][Full Text] [Related]
13. Suppression of hypoxia inducible factor-1alpha (HIF-1alpha) by YC-1 is dependent on murine double minute 2 (Mdm2).
Lau CK; Yang ZF; Lam CT; Tam KH; Poon RT; Fan ST
Biochem Biophys Res Commun; 2006 Oct; 348(4):1443-8. PubMed ID: 16919599
[TBL] [Abstract][Full Text] [Related]
14. Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers.
Bobarykina AY; Minchenko DO; Opentanova IL; Moenner M; Caro J; Esumi H; Minchenko OH
Acta Biochim Pol; 2006; 53(4):789-99. PubMed ID: 17143338
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Aerobic Glycolysis by S-Nitrosoglutathione via HIF-1α Associated GLUT1/Aldolase A Axis in Human Endothelial Cells.
Yan J; Huang X; Zhu D; Lou Y
J Cell Biochem; 2017 Aug; 118(8):2443-2453. PubMed ID: 28121054
[TBL] [Abstract][Full Text] [Related]
16. Isoliquiritigenin inhibits gastric cancer growth through suppressing GLUT4 mediated glucose uptake and inducing PDHK1/PGC-1α mediated energy metabolic collapse.
Yu M; Pan Q; Li W; Du T; Huang F; Wu H; He Y; Wu X; Shi H
Phytomedicine; 2023 Dec; 121():155045. PubMed ID: 37742526
[TBL] [Abstract][Full Text] [Related]
17. YC-1 exerts inhibitory effects on MDA-MB-468 breast cancer cells by targeting EGFR in vitro and in vivo under normoxic condition.
Cheng Y; Li W; Liu Y; Cheng HC; Ma J; Qiu L
Chin J Cancer; 2012 May; 31(5):248-56. PubMed ID: 22507221
[TBL] [Abstract][Full Text] [Related]
18. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species-mediated hypoxia-inducible factor-1α activation.
Jung KH; Lee JH; Thien Quach CH; Paik JY; Oh H; Park JW; Lee EJ; Moon SH; Lee KH
J Nucl Med; 2013 Dec; 54(12):2161-7. PubMed ID: 24221993
[TBL] [Abstract][Full Text] [Related]
20. HIF-1α/YAP Signaling Rewrites Glucose/Iodine Metabolism Program to Promote Papillary Thyroid Cancer Progression.
Song H; Qiu Z; Wang Y; Xi C; Zhang G; Sun Z; Luo Q; Shen C
Int J Biol Sci; 2023; 19(1):225-241. PubMed ID: 36594102
[No Abstract] [Full Text] [Related]
[Next] [New Search]
